HBEGF and cholangiocarcinoma: For example, in cholangiocarcinoma, myCAF can express heparin-binding epidermal growth factor, which induces the activation of epidermal growth factor receptor in cholangiocarcinoma cells, thus promoting the migration and invasion of tumor cells [37].